TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that Jack Talley, President and CEO, will be presenting at the 9th Annual BIO Investor Forum on Tuesday, October 5, 2010 at 1:30 p.m. Pacific time at the Palace Hotel in San Francisco, California. Mr. Talley will present new interim data from the Company’s NCI-sponsored clinical trial of EpiCept™ NP-1 for the treatment of chemotherapy peripheral neuropathy in addition to providing a company overview.
